Genmab A/S (GNMSF)

PNK: GNMSF · Real-Time Price · USD

220.09

14.99 (7.31%)

At close: May 02, 2025, 11:40 AM

Genmab A/S Balance Sheet Statement

Financials in DKK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	9.86B	14.87B	9.89B	8.96B	7.26B	3.55B	532.91M	1.35B	307.02M
Short-Term Investments	11.24B	13.27B	12.43B	10.38B	8.82B	7.42B	5.57B	4.08B	3.61B
Long-Term Investments	228M	134M	133M	371M	1.08B	149M	9.62M	8.76M	1.47M
Other Long-Term Assets	52M	274M	48M	27M	20M	11M	n/a	n/a	n/a
Receivables	6.69B	4.95B	5.71B	3.37B	2.46B	2.99B	1.33B	579M	975.67M
Inventory	62M	57M	-182M	-31M	-249M	n/a	n/a	1.00	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	27.85B	33.14B	28.38B	22.74B	18.79B	13.96B	7.43B	6.06B	4.9B
Property-Plant & Equipment	1.89B	1.64B	1.32B	975M	736M	414M	161.54M	113.42M	32.19M
Goodwill & Intangibles	14.88B	101M	146M	254M	338M	470M	470.36M	124.39M	181.9M
Total Long-Term Assets	17.96B	2.15B	1.9B	1.89B	2.35B	1.18B	1.03B	543.51M	340.6M
Total Assets	45.81B	35.29B	30.28B	24.63B	21.14B	15.14B	8.46B	6.6B	5.24B
Account Payables	n/a	n/a	1.72B	350M	145M	n/a	n/a	n/a	22.27M
Deferred Revenue	24M	33M	33M	26M	26M	-839M	n/a	150.65M	228.15M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	860M	160M	n/a	n/a	150.65M	373.71M
Total Current Liabilities	5.31B	2.48B	1.82B	1.57B	1.25B	938M	443.35M	327.12M	411.54M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	30M	515M	491M	500M	492M	3M	3.29M	3.63M	n/a
Total Long-Term Liabilities	3.81B	1.2B	1.01B	863M	769M	158M	3.29M	3.63M	n/a
Total Liabilities	9.11B	3.68B	2.84B	2.43B	2.02B	1.1B	446.64M	330.75M	411.54M
Total Debt	1.03B	770M	597M	425M	319M	181M	n/a	n/a	n/a
Common Stock	66M	66M	66M	66M	66M	65M	61.5M	61.19M	60.35M
Retained Earnings	23.55B	19.02B	14.97B	10.02B	7.11B	2.13B	-197.46M	-1.85B	-3.11B
Comprehensive Income	490M	60M	98M	81M	54M	98M	91.71M	82.08M	102.88M
Shareholders Equity	36.7B	31.61B	27.44B	22.2B	19.12B	14.05B	8.01B	6.27B	4.83B
Total Investments	11.47B	13.4B	12.56B	10.75B	9.9B	7.57B	5.57B	4.08B	3.61B